Health Care: Drugs

Celgene Corp (CELG: NASDAQ)

$107.02 n/a | n/a%
08/30/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 107.02
52 Week High 128.39
52 Week Low 93.05
Avg. Daily Vol. (Mil) 4.55
Beta (3 year) 1.46
Share Related Items
Mkt Cap (Mil) 82,952.78
Shares Out (Mil) 775.11
Float (Mil) 772.43
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.90
Current Ratio 4.60
LT Debt/ Equity 2.81
Total Debt / Equity 2.81
Valuation Ratios
Price Earnings 52.00
Price/Sales 8.56
Price/Book 16.35
Price/Cash Flow 39.10
Per Share Data
Earnings 2.06
Sales 12.50
Book Value 6.55
Cash Flow 2.74
Business Summary
Celgene Corp is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
General Information
86 Morris Avenue
Summit, NJ 07901
www.celgene.com
Industry : Drugs
Sector: Health Care
Employees: 6971
CEO: Mark J. Alles
Short Interest
Current Month (Mil) 6.09
Previous Month (Mil) 5.87
Short Interest Ratio (Days) 1.30
Management Effectiveness
Return on Equity 33.20
Return on Assets 6.50
Return on Investments 8.70
Profitability
Gross Margin 97.00
EBIT Margin 25.80
Profit Margin 17.40

Portfolios with CELG

Latest CELG Headlines from TheStreet

More Financial News for CELG

Press Releases for CELG

See All Press Releases

Partner Headlines for CELG

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter